Paper41360073
Manufacture of Clostridioides difficile Spores for Experimental Infection of Human Volunteers.
Hensen ADO and 12 others. J Infect Dis, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Manufacture of Clostridioides difficile Spores for Experimental Infection of Human Volunteers. Papers, record 41360073. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41360073
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Manufacture of Clostridioides difficile Spores for Experimental Infection of Human Volunteers.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Clostridioides difficile | Major topic |
| Spores, Bacterial | Major topic |
| Clostridium Infections | Major topic |
| Humans | |
| Quality Control | |
| Capsules | |
| Healthy Volunteers |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Innovative Medicines Initiative | PubMed | |||
| European Union | PubMed | |||
| EFPIA | PubMed |
Source PubMed
References23
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26493844 | Emerging bacterial pathogens: the past and beyond. | Clin Microbiol Infect | 2016 | https://conductscience.org/library/papers/26493844 | PubMed |
| 2 | 28378789 | Novel micelle PCR-based method for accurate, sensitive and quantitative microbiota profiling. | Sci Rep | 2017 | https://conductscience.org/library/papers/28378789 | PubMed |
| 3 | 34911367 | Comparison of Whole-Genome Sequence-Based Methods and PCR Ribotyping for Subtyping of Clostridioides difficile. | J Clin Microbiol | 2022 | https://conductscience.org/library/papers/34911367 | PubMed |
| 4 | 34808546 | Clostridioides difficile spore germination: initiation to DPA release. | Curr Opin Microbiol | 2022 | https://conductscience.org/library/papers/34808546 | PubMed |
| 5 | 39214188 | How to develop a controlled human infection model for Clostridioides difficile. | Clin Microbiol Infect | 2025 | https://conductscience.org/library/papers/39214188 | PubMed |
| 6 | 36287379 | Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection. | Drugs | 2022 | https://conductscience.org/library/papers/36287379 | PubMed |
| 7 | 27001804 | Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection With Vibrio cholerae O1 El Tor. | Clin Infect Dis | 2016 | https://conductscience.org/library/papers/27001804 | PubMed |
| 8 | 35045228 | SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. | N Engl J Med | 2022 | https://conductscience.org/library/papers/35045228 | PubMed |
| 9 | 39884503 | Antimicrobial susceptibility testing of Clostridioides difficile: a dual-site study of three different media and three therapeutic antimicrobials. | Clin Microbiol Infect | 2025 | https://conductscience.org/library/papers/39884503 | PubMed |
| 10 | 36509372 | Clostridioides difficile infection with isolates of cryptic clade C-II: a genomic analysis of polymerase chain reaction ribotype 151. | Clin Microbiol Infect | 2023 | https://conductscience.org/library/papers/36509372 | PubMed |
| 11 | 23323867 | Duodenal infusion of donor feces for recurrent Clostridium difficile. | N Engl J Med | 2013 | https://conductscience.org/library/papers/23323867 | PubMed |
| 12 | 25942722 | Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial. | JAMA | 2015 | https://conductscience.org/library/papers/25942722 | PubMed |
| 13 | 38175470 | Diagnostic Guidance for C. difficile Infections. | Adv Exp Med Biol | 2024 | https://conductscience.org/library/papers/38175470 | PubMed |
| 14 | 34678515 | European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults. | Clin Microbiol Infect | 2021 | https://conductscience.org/library/papers/34678515 | PubMed |
| 15 | 35505774 | Human infection studies: Key considerations for challenge agent development and production. | Wellcome Open Res | 2022 | https://conductscience.org/library/papers/35505774 | PubMed |
| 16 | 39885121 | Metagenomic global survey and in-depth genomic analyses of Ruminococcus gnavus reveal differences across host lifestyle and health status. | Nat Commun | 2025 | https://conductscience.org/library/papers/39885121 | PubMed |
| 17 | 23103666 | Clostridium difficile: a European perspective. | J Infect | 2013 | https://conductscience.org/library/papers/23103666 | PubMed |
| 18 | 25679978 | Development and validation of an internationally-standardized, high-resolution capillary gel-based electrophoresis PCR-ribotyping protocol for Clostridium difficile. | PLoS One | 2015 | https://conductscience.org/library/papers/25679978 | PubMed |
| 19 | 40288746 | Clostridioides difficile is a bacterial priority pathogen. | Anaerobe | 2025 | https://conductscience.org/library/papers/40288746 | PubMed |
| 20 | 29891332 | Experimental infection of human volunteers. | Lancet Infect Dis | 2018 | https://conductscience.org/library/papers/29891332 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42286003 | Experimental human colonisation with non-toxigenic Clostridioides difficile: a placebo-controlled randomised clinical trial. | Nat Commun | 2026 | https://conductscience.org/library/papers/42286003 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41360073
GET https://conductscience.org/api/papers/v1/41360073/references?page=2